Will Experimental Drugs Be Allowed for Hep C Outbreak Victims?
July 2, 2012
Expert: New treatments for hepatitis C patients
By Aaron Sanborn
June 27, 2012
EXETER — A nationally recognized hepatitis C expert from Massachusetts General Hospital told patients infected in the Exeter Hospital hepatitis C outbreak that they may have the option of receiving some cutting edge medication that could treat the infection with few complications.
Dr. Raymond Chung, medical director of the liver transplant program at Massachusetts General Hospital, was the main speaker at a special hepatitis C information night Tuesday at Town Hall. About 100 people attended the meeting hosted by state Rep. Lee Quandt and recently formed patient-advocacy group The Patients Speak.
Chung told the crowd he has been in talks with developers of a new oral treatment for the virus, and they have expressed interest in applying for a “compassion use waiver” with the Food and Drug Administration to use the new treatment exclusively on patients infected in the Exeter Hospital outbreak.
Continue reading this entire article:
Metabolic Health a Priority for Hep C Liver Transplant Recipients
Interferon-Free Treatments Are Imminent for Hep C